Study Title

68Ga-NY104 PET/CT and 18F-FDG PET/CT in Patients With Metastatic Clear Cell Renal Cell Carcinoma: a Prospective, Single Center, Single Arm, Comparative Imaging Trial

Study Details

Description:

This is a prospective, single-center, single-arm, comparative phase 2 study in patients with metastatic clear cell renal cell carcinoma. The goal is to determine the sensitivity of 68Ga-NY104 PET/CT in patients with metastatic clear cell renal cell carcinoma and compare it with 18F-FDG PET/CT.

Contacts:

Li Huo, MD

huoli@pumch.cn

18612672038

Wenjia Zhu, MD

zhuwenjia_pumc@163.com

18614080164

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468